TRUALT TruAlt Bioenergy Q4 FY26 results (Jan–Mar 2026) and concall
TruAlt Bioenergy faced significant challenges in its ethanol business in FY26 due to policy changes and non-compliance by OMCs, leading to a revenue dip and underutilization of capacity. However, the company demonstrated strong performance in its nascent CBG and fuel retail verticals, with substantial growth and healthy margins. Strategic diversification into Sustainable Aviation Fuel (SAF) and continued expansion in CBG are key to mitigating ethanol sector volatility and driving future growth, despite current delays in court-ordered ethanol offtake.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue down 34.3%, net profit down 38.4% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 415 | 907 | 304 | 115 | 713 +72% | 596 −34% |
| EBITDA | 125 | 154 | 42 | -5 | 134 +7% | 129 −16% |
| Net profit | 75 | 112 | 5 | -38 | 69 −8% | 69 −38% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
